Laboratory Corp of America Holdings (LH) Stock Price, Quote & News

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 336 229 1127

Website: www.labcorp.com

Address:

358 South Main Street, Burlington, United States

Nikotime Aug. 25 at 12:57 AM

$LH looks like we've finally busted through and this is going a LOT HIGHER no time like the present

0 · Reply

JFDI Aug. 20 at 10:49 PM

$LH that is a mega base.

0 · Reply

thenewmoney Aug. 19 at 9:56 PM

There’s a new blood test in American healthcare for detecting Alzheimer’s disease. And a publicly traded life sciences giant is behind it. $LH https://share.thenew.money/article/labcorp-launches-first-fda-approved-blood-test-for-alzheimers

0 · Reply

ZacksResearch Aug. 19 at 12:29 PM

$LH unveils new Alzheimer's diagnostic aid! 🧠💡 Labcorp's blood-based Lumipulse pTau-217/Beta Amyloid 42 Ratio test, now FDA-cleared, aids earlier and less invasive Alzheimer's detection, potentially transforming patient care. Following the announcement, LH shares edged up 0.04%, reflecting positive market sentiment. Discover the full impact on LH here 👉 https://www.zacks.com/stock/news/2734464/labcorp-debuts-first-fda-cleared-blood-test-for-alzheimers-stock-up?cid=sm-stocktwits-2-2734464-body-8277&ADID=SYND_STOCKTWITS_TWEET_2_2734464_BODY_8277

0 · Reply

ZacksResearch Aug. 19 at 11:16 AM

$LH just dropped a game-changer. 🧠 First FDA-cleared blood test for Alzheimer’s — and the stock is already moving higher. This milestone puts Labcorp ahead in a massive untapped market where early detection is critical. Full breakdown here 👉 https://www.zacks.com/stock/news/2734464/labcorp-debuts-first-fda-cleared-blood-test-for-alzheimers-stock-up?cid=sm-stocktwits-2-2734464-teaser-8258&ADID=SYND_STOCKTWITS_TWEET_2_2734464_TEASER_8258

0 · Reply

BigSqueezeComing Aug. 18 at 11:14 AM

$LH added

0 · Reply

BigSqueezeComing Aug. 18 at 11:14 AM

$LH This FDA-cleared innovation marks a turning point in Alzheimer’s diagnostics, especially as blood tests enable earlier detection and more timely treatment—critical now that disease-modifying drugs like Leqembi and Kisunla are available.

0 · Reply

BigSqueezeComing Aug. 18 at 11:13 AM

$LH Labcorp has launched the Lumipulse® pTau‑217/Beta Amyloid 42 Ratio, the first FDA-cleared blood-based in-vitro diagnostic (IVD) specifically for aiding the diagnosis of Alzheimer’s disease. It’s now available nationwide through Labcorp’s 2,200+ Patient Service Centers.

0 · Reply

BigSqueezeComing Aug. 18 at 11:12 AM

$LH Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease By PR Newswire | August 18, 2025, 7:00 AM

0 · Reply

99DegreesInvestments Aug. 18 at 1:56 AM

$HIG https://www.businessinsurance.com/business-insurance-2020-data-rankings-bi-top-100/ $BERK $LH $ALL $AYI

0 · Reply

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Jul 30, 2025, 7:12 AM EDT - 25 days ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Jul 29, 2025, 7:00 AM EDT - 26 days ago

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

Jul 25, 2025, 9:45 AM EDT - 4 weeks ago

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Jul 24, 2025, 2:38 PM EDT - 4 weeks ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 12:27 PM EDT - 4 weeks ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 7:00 AM EDT - 4 weeks ago

Labcorp raises annual profit forecast on strong diagnostic testing demand

Jul 24, 2025, 6:50 AM EDT - 4 weeks ago

Labcorp Announces 2025 Second Quarter Results

Jul 22, 2025, 4:15 PM EDT - 4 weeks ago

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

CYH

Jul 10, 2025, 6:50 AM EDT - 6 weeks ago

Labcorp Declares Quarterly Dividend

Jun 30, 2025, 6:58 AM EDT - 7 weeks ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Jun 26, 2025, 4:10 PM EDT - 2 months ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Jun 2, 2025, 7:00 AM EDT - 2 months ago

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

May 30, 2025, 7:00 AM EDT - 3 months ago

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 8, 2025, 4:15 PM EDT - 3 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

Apr 29, 2025, 4:21 PM EDT - 4 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 6:56 AM EDT - 4 months ago

Labcorp beats quarterly profit estimate on diagnostic test demand

Apr 29, 2025, 6:50 AM EDT - 4 months ago

Labcorp Announces 2025 First Quarter Results

Apr 23, 2025, 7:00 AM EDT - 4 months ago

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Apr 11, 2025, 5:32 AM EDT - 4 months ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Apr 2, 2025, 7:00 AM EDT - 5 months ago

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Apr 1, 2025, 8:32 AM EDT - 5 months ago

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

Mar 31, 2025, 4:15 PM EDT - 5 months ago

Labcorp to Announce First Quarter Financial Results on April 29, 2025

Mar 11, 2025, 7:00 AM EDT - 5 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Feb 24, 2025, 7:32 AM EST - 6 months ago

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

Feb 13, 2025, 2:12 PM EST - 6 months ago

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'

Feb 6, 2025, 3:42 PM EST - 7 months ago

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 1:22 PM EST - 7 months ago

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook

Feb 6, 2025, 6:55 AM EST - 7 months ago

Labcorp forecasts 2025 revenue above estimates on diagnostic test demand

Feb 6, 2025, 6:50 AM EST - 7 months ago

Labcorp Announces 2024 Fourth Quarter and Full Year Results

Jan 10, 2025, 4:15 PM EST - 8 months ago

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 6:02 PM EST - 8 months ago

LABCORP DECLARES QUARTERLY DIVIDEND

Jan 8, 2025, 4:15 PM EST - 8 months ago

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Jan 8, 2025, 8:15 AM EST - 8 months ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

BIO

Dec 17, 2024, 7:00 AM EST - 8 months ago

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

Nov 29, 2024, 12:16 PM EST - 9 months ago

Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand

Nov 26, 2024, 7:52 AM EST - 9 months ago

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Nov 20, 2024, 4:23 AM EST - 9 months ago

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Nov 19, 2024, 7:00 AM EST - 9 months ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

ONC

Nov 4, 2024, 9:00 AM EST - 10 months ago

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

Oct 24, 2024, 2:00 PM EDT - 10 months ago

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 11:25 AM EDT - 10 months ago

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact

Oct 24, 2024, 7:10 AM EDT - 10 months ago

Labcorp beats quarterly estimates on diagnostic test demand

Oct 24, 2024, 6:50 AM EDT - 10 months ago

Labcorp Announces 2024 Third Quarter Results

Oct 16, 2024, 8:00 AM EDT - 11 months ago

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

Oct 10, 2024, 8:30 AM EDT - 11 months ago

Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test

Sep 24, 2024, 4:16 PM EDT - 11 months ago

Labcorp to Announce Third Quarter Financial Results on October 24, 2024

Sep 18, 2024, 9:00 AM EDT - 1 year ago

CommonWell Health Alliance Welcomes Labcorp as Newest Member

Sep 18, 2024, 7:00 AM EDT - 1 year ago

Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience

Sep 16, 2024, 6:35 PM EDT - 1 year ago

LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034

Nikotime Aug. 25 at 12:57 AM

$LH looks like we've finally busted through and this is going a LOT HIGHER no time like the present

0 · Reply

JFDI Aug. 20 at 10:49 PM

$LH that is a mega base.

0 · Reply

thenewmoney Aug. 19 at 9:56 PM

0 · Reply

ZacksResearch Aug. 19 at 12:29 PM

0 · Reply

ZacksResearch Aug. 19 at 11:16 AM

0 · Reply

BigSqueezeComing Aug. 18 at 11:14 AM

$LH added

0 · Reply

BigSqueezeComing Aug. 18 at 11:14 AM

0 · Reply

BigSqueezeComing Aug. 18 at 11:13 AM

0 · Reply

BigSqueezeComing Aug. 18 at 11:12 AM

$LH Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease By PR Newswire | August 18, 2025, 7:00 AM

0 · Reply

99DegreesInvestments Aug. 18 at 1:56 AM

$HIG https://www.businessinsurance.com/business-insurance-2020-data-rankings-bi-top-100/ $BERK $LH $ALL $AYI

0 · Reply

StockAutoPro Aug. 11 at 9:41 PM

$LH: Buy target $266.0 Sell target $281.41 Promising clinical trial results hint at upside potential for this leading biotech firm.

0 · Reply

ChillllinTheMost Jul. 28 at 1:21 PM

$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?

0 · Reply

JarvisFlow Jul. 25 at 3:30 PM

UBS has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Buy with a target price of 282 → 305.

0 · Reply

JarvisFlow Jul. 25 at 1:50 PM

Evercore ISI Group updates rating for Labcorp Hldgs ( $LH ) to Outperform, target set at 285 → 300.

0 · Reply

JarvisFlow Jul. 25 at 1:00 PM

Morgan Stanley has updated their rating for Labcorp Hldgs ( $LH ) to Overweight with a price target of 306.

0 · Reply

JarvisFlow Jul. 25 at 12:00 PM

Baird has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Outperform with a target price of 290 → 302.

0 · Reply

StocktwitsNews Jul. 24 at 6:39 PM

Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330 $LH $VTI $VOO https://stocktwits.com/news/equity/markets/labcorp-raises-full-year-guidance-after-q2-earnings-beat-wall-street-expectations/ch8z5pVR5HC

0 · Reply

topstockalerts Jul. 24 at 5:55 PM

$LH trying to consolidate here..

0 · Reply

ZacksResearch Jul. 24 at 5:08 PM

$LH just crushed Q2 — here’s what’s fueling the move 🚀 Double-digit EPS growth, margin expansion, and a raised 2025 outlook pushed the stock higher in pre-market. Full breakdown here 👉 https://www.zacks.com/stock/news/2612878/labcorp-q2-earnings-revenues-beat-estimates-stock-up-in-pre-market?cid=sm-stocktwits-2-2612878-teaser-3720&ADID=SYND_STOCKTWITS_TWEET_2_2612878_TEASER_3720

0 · Reply

schaeffers Jul. 24 at 5:03 PM

$LH is spiking! Up nearly 9% after a strong earnings beat and raised profit forecast & leading $SPX. It smashed thru resistance at $260–$265 level and clocked a record high $283.47 out of the gate today, pacing for its best day since Aug. 2024. Now +16.8% YTD. 📈📈

0 · Reply

TalkMarkets Jul. 24 at 4:37 PM

#Nasdaq, S&P 500 Notch More Records; #Dow Gaps Lower $DOW $LH $LVS $QQQ $SPX https://talkmarkets.com/content/us-markets/nasdaq-sp-500-notch-more-records-dow-gaps-lower?post=511261

0 · Reply

ZacksResearch Jul. 24 at 3:25 PM

$LH beats earnings and raises guidance 📈 Labcorp's Q2 adjusted EPS of $4.35 beat the Zacks Consensus Estimate by 5.07%, with revenues up 9.5% year over year. The company also lifted its 2025 revenue and EPS outlook, primarily driven by currency and underlying business strength. See why LH could be a stock to watch 👉 https://www.zacks.com/stock/news/2612878/labcorp-q2-earnings-revenues-beat-estimates-stock-up-in-pre-market?cid=sm-stocktwits-2-2612878-body-3624&ADID=SYND_STOCKTWITS_TWEET_2_2612878_BODY_3624

0 · Reply

Market Cap	23.12B
Revenue (ttm)	13.01B
Net Income (ttm)	746.00M
EPS (ttm)	N/A
PE Ratio	18.27
Forward PE	16.97
Profit Margin	5.73%
Debt to Equity Ratio	0.60

Volume	483,000
Avg Vol	719,108
Day's Range	N/A - N/A
Shares Out	83.10M
Stochastic %K	84%
Beta	0.78
Analysts	Strong Sell
Price Target	$295.00